TY  - GEN
AU  - Johannsen,Manfred
AU  - Flörcken,Anne
AU  - Bex,Axel
AU  - Roigas,Jan
AU  - Cosentino,Marco
AU  - Ficarra,Vincenzo
AU  - Kloeters,Christian
AU  - Rief,Matthias
AU  - Rogalla,Patrik
AU  - Miller,Kurt
AU  - Grünwald,Viktor
TI  - Can tyrosine kinase inhibitors be discontinued in patients with metastatic renal cell carcinoma and a complete response to treatment? A multicentre, retrospective analysis
SN  - 1873-7560
PY  - 2009///1103
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Benzenesulfonates
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Indoles
KW  - Kidney Neoplasms
KW  - Magnetic Resonance Imaging
KW  - methods
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Neoplasm Recurrence, Local
KW  - mortality
KW  - Neoplasm Staging
KW  - Nephrectomy
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Protein Kinase Inhibitors
KW  - Protein-Tyrosine Kinases
KW  - antagonists & inhibitors
KW  - Pyridines
KW  - Pyrroles
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Sorafenib
KW  - Sunitinib
KW  - Survival Analysis
KW  - Tomography, X-Ray Computed
KW  - Treatment Outcome
KW  - Withholding Treatment
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.1016/j.eururo.2008.10.021
ER  -